Low risk

Modarate risk

Important risk

Most important risk

Total

p-value

N = 37

n

%

N = 51

n

%

N = 58

n

%

N = 174

n

%

N = 320

n

%

Age (years)

0.075

<50

14

37.8

22

43.1

10

17.2

28

16.1

74

23.1

≥50

23

62.2

29

56.9

48

82.8

146

83.9

246

76.9

Sex

0.03

Male

22

59.5

20

39.2

29

50

71

40.8

142

44.4

Female

15

40.5

31

60.8

29

50

103

59.2

178

55.6

Social-economical level

0.02

High

5

13.5

4

7.8

7

12.1

10

5.7

26

8.1

Middle

15

40.5

23

45.1

31

53.4

76

43.7

145

45.3

Low

17

46

24

47.1

20

34.5

88

50.6

149

46.6

Hypertension

<0.001

No

19

51.4

9

17.6

15

25.9

7

4

50

15.6

Yes

18

48.6

42

82.4

43

74.1

167

96

270

84.4

Dyslipidemia

0.245

No

32

86.5

39

76.5

48

82.8

128

73.6

247

77.2

Yes

5

13.5

12

23.5

10

46

26.4

73

22.8

Complications

None

8

21.6

2

3.9

0

0

0

0

10

3.1

<0.001

Microangiopathy

17

46

43

84.3

41

70.7

164

94.3

265

82.8

<0.001

Macroangiopathy

5

13.5

11

21.6

8

13.8

39

22.4

63

19.7

0.082

OAD

<0.001

Yes

28

75.7

36

70.6

46

79.3

89

51.1

199

62.2

No

9

24.3

15

29.4

12

20.7

85

48.9

121

37.8

Insulin

0.308

Yes

13

35.1

14

27.5

18

31

70

40.2

115

35.9

No

24

64.9

37

72.5

40

69

104

59.8

205

64.1

BRAS

<0.001

Yes

11

29.7

37

72.5

29

50

126

72.4

203

63.4

No

26

70.3

14

27.5

29

50

48

27.6

117

36.6

Calcium channel blockers

<0.001

Yes

7

18.9

16

31.4

24

41.4

94

54

141

44.1

No

30

81.1

35

68.6

34

58.6

80

46

179

55.9

Diuretics

0.356

Oui

5

13.5

14

27.5

10

17.2

32

18.4

61

19.1

Non

32

86.5

37

72.5

48

82.8

142

81.6

259

80.9